A detailed history of Castleark Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 386,366 shares of ADMA stock, worth $6.12 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
386,366
Previous 692,966 44.24%
Holding current value
$6.12 Million
Previous $13.9 Million 52.17%
% of portfolio
0.24%
Previous 0.58%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$15.62 - $22.62 $4.79 Million - $6.94 Million
-306,600 Reduced 44.24%
386,366 $6.63 Million
Q3 2024

Nov 14, 2024

SELL
$11.21 - $20.03 $1.63 Million - $2.91 Million
-145,120 Reduced 17.32%
692,966 $13.9 Million
Q2 2024

Aug 13, 2024

BUY
$5.98 - $11.18 $119,456 - $223,331
19,976 Added 2.44%
838,086 $9.37 Million
Q1 2024

May 15, 2024

BUY
$4.4 - $6.74 $3.6 Million - $5.51 Million
818,110 New
818,110 $5.4 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.11B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.